Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-040489
Filing Date
2021-02-12
Accepted
2021-02-12 10:15:59
Documents
1
Group Members
MACQUARIE BANK LTDMACQUARIE INVESTMENT MANAGEMENT AUSTRALIA LTDMACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUSTMACQUARIE INVESTMENT MANAGEMENT GLOBAL LTDMACQUARIE INVESTMENT MANAGEMENT HOLDINGS INC

Document Format Files

Seq Description Document Type Size
1 SC 13G d127891dsc13g.htm SC 13G 136097
  Complete submission text file 0001193125-21-040489.txt   137862
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43329 | Film No.: 21623767
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000
Business Address 50 MARTIN PLACE SYDNEY, NSW 2000 C3 2000 212.231.1000
MACQUARIE GROUP LTD (Filed by) CIK: 0001418333 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SC 13G